Healthscope bid raises hopes for return of Asian buy-outs
The Carlyle Group and Texas Pacific Group look set to give Asia’s struggling leveraged finance market a welcome shot in the arm after tabling a A$1.74bn ($1.525bn) bid for Australia’s Healthscope. A successful acquisition would pave the way for Australia’s biggest leveraged buy-out since 2007, in the latest sign of a rebound across the region.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts